Bati Eddermed: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Bati Eddermed
Largest movements
- Cash +€11,511
up €11,511 (+1,344%), from €856 to €12,367
mainly Net result for the year (+€10,695) and Receivables within one year (+€3,391)
- Receivables within one year -€3,391
down €3,391 (-12.6%), from €26,846 to €23,455
of which Trade receivables: -€1,700
- Profit (loss) carried forward +€10,695
up €10,695 (+72.8%), from €14,695 to €25,390
- Trade debts -€2,722
down €2,722 (-63.4%), from €4,295 to €1,573
- Turnover +€13,093
new in 2025: €13,093
- Gross operating margin +€8,664
up €8,664 (+321%), from €2,701 to €11,365
- Purchases and services +€1,727
new in 2025: €1,727
- Taxes -€1,245
no longer reported in 2025 (was €1,245)
- Other operating charges +€416
new in 2025: €416
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €28,016 | €36,136 | +€8,120 | +29.0% |
| Fixed assets | 21/28 | €313 | €313 | = | 0.0% |
| Financial fixed assets | 28 | €313 | €313 | = | 0.0% |
| Current assets | 29/58 | €27,703 | €35,823 | +€8,120 | +29.3% |
| Amounts receivable within one year | 40/41 | €26,846 | €23,455 | -€3,391 | -12.6% |
| Trade receivables | 40 | €1,700 | - | -€1,700 | |
| Other amounts receivable | 41 | €25,146 | €23,455 | -€1,691 | -6.7% |
| Cash at bank and in hand | 54/58 | €856 | €12,367 | +€11,511 | +1,344% |
| Total equity and liabilities | 10/49 | €28,016 | €36,136 | +€8,120 | +29.0% |
| Equity | 10/15 | €20,895 | €31,590 | +€10,695 | +51.2% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Profit (loss) carried forward | 14 | €14,695 | €25,390 | +€10,695 | +72.8% |
| Amounts payable | 17/49 | €7,120 | €4,545 | -€2,575 | -36.2% |
| Amounts payable within one year | 42/48 | €7,120 | €4,545 | -€2,575 | -36.2% |
| Trade debts | 44 | €4,295 | €1,573 | -€2,722 | -63.4% |
| Suppliers | 440/4 | €4,295 | €1,573 | -€2,722 | -63.4% |
| Taxes, remuneration and social security | 45 | €16 | €163 | +€147 | +940% |
| Taxes | 450/3 | - | €147 | +€147 | |
| Remuneration and social security | 454/9 | €16 | €16 | = | 0.0% |
| Other amounts payable | 47/48 | €2,810 | €2,810 | = | 0.0% |
| Turnover | 70 | - | €13,093 | +€13,093 | |
| Goods, raw materials, services and sundry goods | 60/61 | - | €1,727 | +€1,727 | |
| Other operating charges | 640/8 | - | €416 | +€416 | |
| Gross operating margin | 9900 | €2,701 | €11,365 | +€8,664 | +321% |
| Operating profit (loss) | 9901 | €2,701 | €10,949 | +€8,247 | +305% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €374 | €254 | -€120 | -32.1% |
| Recurring financial charges | 65 | €215 | €254 | +€38 | +17.8% |
| Non-recurring financial charges | 66B | €158 | - | -€158 | |
| Profit (loss) for the period before taxes | 9903 | €2,328 | €10,695 | +€8,367 | +359% |
| Income taxes | 67/77 | €1,245 | - | -€1,245 | |
| Profit (loss) for the period | 9904 | €1,083 | €10,695 | +€9,612 | +888% |
| Profit (loss) for the period to be appropriated | 9905 | €1,083 | €10,695 | +€9,612 | +888% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.